Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice.
Huntington's disease (HD) is a neurodegenerative disorder caused by an elongation of CAG repeats in the HD gene, which encodes a mutant copy of huntingtin with an expanded polyglutatmine repeat. Individuals who are affected by the disease suffer from motor, cognitive, and emotional impairments. Levels of certain striatal-enriched mRNAs decrease in both HD patients and transgenic HD mice prior to the development of motor symptoms and neuronal cell death. Ciliary neurotrophic factor (CNTF) has been shown to protect neurons against chemically induced toxic insults in vitro and in vivo. To test the hypothesis that CNTF might protect neurons from the negative effects of the mutant huntingtin protein in vivo, CNTF was continuously expressed following transduction of the striatum by recombinant adeno-associated viral vectors (rAAV2). Wild-type and R6/1 HD transgenic (R6/1) mice that received bilateral or unilateral intrastriatal injections of rAAV2-CNTF experienced weight loss. The CNTF-treated R6/1 HD transgenic mice experienced motor impairments at an earlier age than expected compared with age-matched control R6/1 HD transgenic animals. CNTF also caused abnormal behavior in WT mice. In addition to behavioral impairments, in situ hybridization showed that, in both WT and R6/1 mice, CNTF expression caused a significant decrease in the levels of striatal-enriched transcripts. Overall, continuous expression of striatal CNTF at the dose mediated by the expression cassette used in this study was detrimental to HD and wild-type mice.
Denovan-Wright
Eileen M
EM
Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
Attis
Marissa
M
Rodriguez-Lebron
Edgardo
E
Mandel
Ronald J
RJ
D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D020934:Ciliary Neurotrophic Factor / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D003342:Corpus Striatum / Q000378:metabolism*; D015536:Down-Regulation / Q000235:genetics / Q000502:physiology*; D006801:Humans; D006816:Huntington Disease / Q000150:complications / Q000235:genetics / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008822:Mice, Transgenic; D019957:Motor Skills Disorders / Q000209:etiology / Q000235:genetics / Q000378:metabolism*; D013997:Time Factors
D020934:Ciliary Neurotrophic Factor